Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

Hearing Loss More Prominent In Men, Says Miracle-Ear
When it comes to maintaining their health, men tend to wait for serious symptoms to appear before taking the necessary precautions. Indications of serious physical conditions, however, can oftentimes take a silent form. Take hearing loss: The condition affects more than 31 million people, 65 percent of whom are men, but the signs of the condition are typically overlooked. With that in mind, Miracle-Ear is honoring National Men"s Health Week, which begins on June 15th, with advice on what to look - or listen - for to determine if men are living with diminished hearing capacity.
generic viagra online
ZymoGenetics Reports Encouraging Preliminary Results From Phase 2 Study Of IL-21 In Metastatic Melanoma Conducted By NCIC
ZymoGenetics, Inc. (NASDAQ:ZGEN) announced that Interleukin 21 (IL-21) demonstrated an impressive overall response rate in the treatment of metastatic melanoma. In interim Phase 2 results from 24 patients, 29 percent showed a partial response, with an additional 33 percent of patients showing stable disease in this difficult to treat disease.
plastic surgery before after
News of the day
For Improved Pitching, Pay Attention To The Pelvis
A strong throwing arm isn"t the only factor on which to judge pitchers; experts at the American College of Sports Medicine"s 56th Annual Meeting in Seattle say the pelvis may be a strong predictor of future pitching success in baseball.
Diagnostics

Elekta Receives FDA 510 (k) Clearance For Monaco VMAT Treatment Planning Solution

Elekta (STO:EKTAB) has received FDA 510(k) clearance for the VMAT (Volumetric Modulated Arc Therapy) enhancement to Monaco®, treatment planning solution. Monaco treatment planning system, introduces a set of tools to make the treatment planning process easier, more straightforward and clinically reliable. For the clinicians this gives the flexibility and control needed for complex treatment. For the clinic administrator it provides reduced planning time and increased clinical throughput. "We are extremely proud and very pleased to receive clearance to add this VMAT technique to Monaco in the U.S. market," said Rob Cessac, Product Manager for Elekta CMS Software. "Our continued support and development of leading approaches to cancer treatment promises to create a positive future for clinicians and patients." The biologically-based Monaco IMRT (Intensity Modulated Radiotherapy) treatment planning system features constrained optimization and dose calculation algorithms and help reduce the time needed to optimize IMRT plans. Monaco has been available for use clinically for the past two years for step-and-shoot IMRT planning. The product was developed in cooperation with Eberhard Karls University Tuebingen in Germany. For the latest Monaco with VMAT news, visit http://www.elekta.com. Elekta


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009